TickerFacts.

Coherus Oncology, Inc. (CHRS): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$175.17M
Year ended 2023-12-31
$146.91M2012-12-31: -$20.03M2013-12-31: $15.05M2014-12-31: -$26.78M2015-12-31: -$114.15M2016-12-31: -$259.06M2017-12-31: -$204.86M2018-12-31: -$160.06M2019-12-31: $26.53M2020-12-31: $146.91M2021-12-31: -$38.72M2022-12-31: -$243.16M2023-12-31: -$175.17M-$175.17M
2012-12-31 Free Cash Flow (USD) 2023-12-31
Period endedFree Cash FlowChange YoYSource filing
2023-12-31-$175.17Mn/m2025-03-17, From 2023-01-01
2022-12-31-$243.16Mn/m2025-03-17, From 2022-01-01
2021-12-31-$38.72Mn/m2024-03-15, From 2021-01-01
2020-12-31$146.91M+453.7%2023-03-06, From 2020-01-01
2019-12-31$26.53Mn/m2022-02-23, From 2019-01-01
2018-12-31-$160.06Mn/m2021-02-25, From 2018-01-01
2017-12-31-$204.86Mn/m2020-02-27, From 2017-01-01
2016-12-31-$259.06Mn/m2019-02-28, From 2016-01-01
2015-12-31-$114.15Mn/m2018-03-08, From 2015-01-01
2014-12-31-$26.78Mn/m2017-03-14, From 2014-01-01
2013-12-31$15.05Mn/m2016-02-29, From 2013-01-01
2012-12-31-$20.03Mn/a2015-03-23, From 2012-01-01